Paper · 23250412
Cited by200
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 370 citations.
1 to 20 of 200
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919905 | Autologous erythrocyte microparticles drive antitumour T cell immunity via haem-mediated dendritic cell activation. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42919905 | PubMed |
| 42606797 | Regenerative strategies for ALS: stem cells and extracellular vesicles. | Discov Nano | 2026 | https://conductscience.org/library/papers/42606797 | PubMed |
| 41944389 | Chemoradiotherapy-Integrated Tumor Cell-Derived Microparticles Mediate Tumor Eradication in Malignant Pleural Effusion. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/41944389 | PubMed |
| 41629133 | Oncolytic virus OH2 induces PD-L1 upregulation via NF-κB signaling and synergizes with anti-PD-L1 therapy in prostate cancer through a targeted extracellular vesicle delivery system. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41629133 | PubMed |
| 41261428 | Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41261428 | PubMed |
| 41179975 | Extracellular Vesicle-Based Therapeutic Cargo Delivery for Cancer Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41179975 | PubMed |
| 41016975 | Immune-based cancer therapies: mechanistic insights, clinical progress, and future directions. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/41016975 | PubMed |
| 40871036 | Extracellular Vesicle-Mediated Delivery of AntimiR-Conjugated Bio-Gold Nanoparticles for In Vivo Tumor Targeting. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40871036 | PubMed |
| 40650799 | Stem Cell for Cancer Immunotherapy: Current Approaches and Challenges. | Stem Cell Rev Rep | 2025 | https://conductscience.org/library/papers/40650799 | PubMed |
| 40636726 | The potential role of extracellular vesicles as hepatic diagnostic and therapeutic tools: Can the dream come true? | ILIVER | 2024 | https://conductscience.org/library/papers/40636726 | PubMed |
| 40321799 | The Radiosensitizing Effect of Tumor-Derived Microparticles Co-Loaded with Sorafenib and Gold Nanoparticles on Hepatocellular Carcinoma. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40321799 | PubMed |
| 40078996 | Prospect of extracellular vesicles in tumor immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40078996 | PubMed |
| 39961904 | Exosomes and solid cancer therapy: where are we now? | Med Oncol | 2025 | https://conductscience.org/library/papers/39961904 | PubMed |
| 39875472 | A study on the production of extracellular vesicles derived from novel immortalized human placental mesenchymal stromal cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/39875472 | PubMed |
| 39547584 | Roles of extracellular vesicles from mesenchymal stem cells in regeneration. | Mol Cells | 2024 | https://conductscience.org/library/papers/39547584 | PubMed |
| 39493304 | Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39493304 | PubMed |
| 39339242 | Characterizing Extracellular Vesicles Generated from the Integra CELLine Culture System and Their Endocytic Pathways for Intracellular Drug Delivery. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339242 | PubMed |
| 39229670 | Exosomes That Have Different Cellular Origins Followed by the Impact They Have on Prostate Tumor Development in the Tumor Microenvironment. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/39229670 | PubMed |
| 39204374 | Extracellular Vesicles as Drug Delivery System for Cancer Therapy. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39204374 | PubMed |
| 39113040 | Harnessing exosomes as cancer biomarkers in clinical oncology. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39113040 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/23250412/cited_by